Syndax Pharmaceuticals Inc·4

Feb 12, 4:00 PM ET

Chen Henry 4

4 · Syndax Pharmaceuticals Inc · Filed Feb 12, 2018

Insider Transaction Report

Form 4
Period: 2018-02-08
Chen Henry
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-02-08+10,00010,000 total
    Exercise: $9.63Exp: 2028-02-08Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]1/36th of the shares subject to the option shall vest monthly over a three-year period.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT